Iron pills may weaken immunity in rare bleeding disorder
NCT ID NCT07111598
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how iron supplements, often given for anemia, affect the immune system in people with Hereditary Haemorrhagic Telangiectasia (HHT), a rare genetic disorder that causes frequent nosebleeds and abnormal blood vessels. About 155 adults with HHT will be divided into groups based on whether they take iron by mouth, through a vein, or not at all. Researchers will measure changes in immune cells to understand if iron helps or harms the body's defenses.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY HAEMORRHAGIC TELANGIECTASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Femme-Mère-Enfant
RECRUITINGBron, Rhone, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.